Bridging Artificial Intelligence and Wet Lab: a new era in Antibody Development
Webinar on demand
Monoclonal antibody-based therapies are expanding fast, driven by their tremendous therapeutic potential. In parallel, artificial intelligence is redefining the way antibodies are discovered and optimized—especially for complex targets such as Multi-Pass Membrane Proteins. When combined with wet lab expertise, AI plays a crucial role across all stages of development.
Replay Webinar Form
Your Speaker


What will you learn ?
- The role of monoclonal antibodies and their main therapeutic applications
- Key strategies to tackle complex targets, including Multi-Pass Membrane Proteins
- How AI is transforming antibody discovery, from screening to optimization
- Why wet lab expertise remains indispensable in the AI era
- Why the future is now: designing de novo antibodies directly in silico
Monoclonal antibody-based therapies are expanding fast, driven by their tremendous therapeutic potential. In parallel, artificial intelligence is redefining the way antibodies are discovered and optimized—especially for complex targets such as Multi-Pass Membrane Proteins. When combined with wet lab expertise, AI plays a crucial role across all stages of development.
What will you'll learn ?